Skip to content

Study of efficacy of Varunadi Kshara in the treatmemt of Mutrashmari with special reference to urolithiasis

Study of efficacy of Varunadi Kshara in the treatment of Mutrashmari with special reference to Urolithiasis: Randomized controlled clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050404
Enrollment
30
Registered
2023-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N20-N23- Urolithiasis

Interventions

None listed

Sponsors

Dr. Mataprasad Rakesh Sharma
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient of Mutrashmari of 4mm to max 12mm. 2. Patient of obstructive as well as non-obstructive pathology with normal KFT. 3. Patient of Mutrashmari with renal, ureteric, UVJ and vesical calculus.

Exclusion criteria

Exclusion criteria: 1. Patients of obstructive pathology with changes of severe hydronephrosis in USG. 2. Patient is having uncontrolled diabetes, hypertension, Asthma and other major systemic illness. 3. Impaired renal function. 4. Pregnant and lactating mother. 5. Urinary calculus having size more than 12mm. 6. Kshala ayogya i.e. Raktapitta, Jwar, Pittaprakruti, Baala, Vruddha, Durbala, Bhrama, Mada, Murchchha, Timira.

Design outcomes

Primary

MeasureTime frame
Reduced size or expulsion of MutrashmariTimepoint: 28 days

Secondary

MeasureTime frame
1. Reduced size or expulsion of Mutrashmari 2. Decreased pain 3. Decreased burning micturition 4. Decreased haematuria 5. Decreased vomitingTimepoint: 28 days

Countries

India

Contacts

Public ContactDr Rajendra Sonekar

Government Ayurved College and Hospital, Vazirabad, Nanded

rajendra.sonekar@gmail.com9822578033

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026